Immunostics guilty of fraudulent export notes
This article was originally published in Clinica
Immunostics, a US manufacturer of microbiological, serological and immunological reagents, has pleaded guilty in the US District Court of Newark, New Jersey, to providing fraudulent export documents to the US Department of Commerce and the US Customs Service. Sentencing has not yet occurred but the parties have entered into a plea agreement in which the Ocean, New Jersey-based company would be fined $48,000.
You may also be interested in...
Policy experts predicted how the incoming Biden administration will handle health care issues at a recent Alliance for Health Policy webinar. Rachel Nuzum, VP of state and federal policy at The Commonwealth Fund, said telehealth could be a priority.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.